These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8515074)

  • 61. Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12.
    Yu WG; Yamamoto N; Takenaka H; Mu J; Tai XG; Zou JP; Ogawa M; Tsutsui T; Wijesuriya R; Yoshida R; Herrmann S; Fujiwara H; Hamaoka T
    Int Immunol; 1996 Jun; 8(6):855-65. PubMed ID: 8671675
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation.
    Heseler K; Spekker K; Schmidt SK; MacKenzie CR; Däubener W
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):273-81. PubMed ID: 18205804
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of toxoplasmostasis in a human glioblastoma by interferon gamma.
    Däubener W; Pilz K; Seghrouchni Zennati S; Bilzer T; Fischer HG; Hadding U
    J Neuroimmunol; 1993 Mar; 43(1-2):31-8. PubMed ID: 8384636
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells.
    Nagineni CN; Pardhasaradhi K; Martins MC; Detrick B; Hooks JJ
    Infect Immun; 1996 Oct; 64(10):4188-96. PubMed ID: 8926087
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inducible anti-parasitic effector mechanisms in human uroepithelial cells: tryptophan degradation vs. NO production.
    Däubener W; Posdziech V; Hadding U; MacKenzie CR
    Med Microbiol Immunol; 1999 Mar; 187(3):143-7. PubMed ID: 10206145
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells.
    Mao R; Zhang J; Jiang D; Cai D; Levy JM; Cuconati A; Block TM; Guo JT; Guo H
    J Virol; 2011 Jan; 85(2):1048-57. PubMed ID: 21084489
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interferon-gamma-dependent/independent expression of indoleamine 2,3-dioxygenase. Studies with interferon-gamma-knockout mice.
    Takikawa O; Tagawa Y; Iwakura Y; Yoshida R; Truscott RJ
    Adv Exp Med Biol; 1999; 467():553-7. PubMed ID: 10721099
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cloning and expression of a cDNA encoding mouse indoleamine 2,3-dioxygenase.
    Habara-Ohkubo A; Takikawa O; Yoshida R
    Gene; 1991 Sep; 105(2):221-7. PubMed ID: 1937018
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures.
    Paguirigan AM; Byrne GI; Becht S; Carlin JM
    Infect Immun; 1994 Apr; 62(4):1131-6. PubMed ID: 8132317
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytokine mediated regulation of interferon-gamma-induced IDO activation.
    MacKenzie CR; González RG; Kniep E; Roch S; Däubener W
    Adv Exp Med Biol; 1999; 467():533-9. PubMed ID: 10721097
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts.
    Gupta SL; Carlin JM; Pyati P; Dai W; Pfefferkorn ER; Murphy MJ
    Infect Immun; 1994 Jun; 62(6):2277-84. PubMed ID: 8188349
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects.
    Carlin JM; Ozaki Y; Byrne GI; Brown RR; Borden EC
    Experientia; 1989 Jun; 45(6):535-41. PubMed ID: 2472288
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of interferon-gamma resistant mutants that are possibly defective in their signaling mechanism.
    Feng GS; Dai W; Gupta SL; Werner-Felmayer G; Wachter H; Takikawa O; Taylor MW
    Mol Gen Genet; 1991 Nov; 230(1-2):91-6. PubMed ID: 1720865
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of the
    Islam MM; Jelocnik M; Huston WM; Timms P; Polkinghorne A
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358337
    [No Abstract]   [Full Text] [Related]  

  • 75. Protamine enhances the activity of human recombinant interferon-gamma.
    Däubener W; Gutsche M; Nockemann S; MacKenzie C; Seghrouchni S; Hadding U
    J Interferon Cytokine Res; 1996 Jul; 16(7):531-6. PubMed ID: 8836919
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan.
    Pfefferkorn ER; Eckel M; Rebhun S
    Mol Biochem Parasitol; 1986 Sep; 20(3):215-24. PubMed ID: 3093859
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of prostaglandin synthesis and cell adhesion by a tryptophan catabolizing enzyme.
    Marshall B; Keskin DB; Mellor AL
    BMC Biochem; 2001; 2():5. PubMed ID: 11375052
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma.
    Ozaki Y; Edelstein MP; Duch DS
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1242-6. PubMed ID: 3124115
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The development of antibody to the interferon-induced indoleamine 2,3-dioxygenase and the study of the regulation of its synthesis.
    Rubin BY; Anderson SL; Hellermann GR; Richardson NK; Lunn RM; Valinsky JE
    J Interferon Res; 1988 Oct; 8(5):691-702. PubMed ID: 2466915
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions.
    Schmidt SK; Ebel S; Keil E; Woite C; Ernst JF; Benzin AE; Rupp J; Däubener W
    PLoS One; 2013; 8(5):e63301. PubMed ID: 23675474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.